We are live on !
Find out more
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
Turnover
60.27%
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.6B
AUM Growth
+$1.42B
(+10%)
Cap. Flow
+$81.1M
Cap. Flow % of AUM
Cap. Flow %
0.52%
Top 10 Holdings %
Top 10 Hldgs %
22.3%
Holding
1,397
New
435
Increased
253
Reduced
266
Closed
407
Avg Time Held
Equity + Options
0.3
years
Top 10 Avg Time Held
Equity + Options
0.2
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$311M |
| 2 |
Abbott
ABT
|
+$125M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$121M |
| 4 |
SpaceX
SPCX
|
+$116M |
| 5 |
Procter & Gamble
PG
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Datadog
DDOG
|
+$128M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$111M |
| 3 |
Elastic
ESTC
|
+$110M |
| 4 |
Twilio
TWLO
|
+$110M |
| 5 |
Intuitive Surgical
ISRG
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.5% |
| 2 | Financials | 16.81% |
| 3 | Miscellaneous | 15.64% |
| 4 | Technology | 13.57% |
| 5 | Healthcare | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
826
IDEAYA Biosciences
IDYA
$3.44B
| $141K | ﹤0.01% |
+3,778
| New | +$116K |
2026 Q2
0 quarters
|
|
827
Phibro Animal Health
PAHC
$1.59B
| $139K | ﹤0.01% |
+4,442
| New | +$187K |
2026 Q2
0 quarters
|
|
828
Lyft
LYFT
$6.46B
| $137K | ﹤0.01% |
+9,363
| New | +$131K |
2026 Q2
0 quarters
|
|
829
MillerKnoll
MLKN
$1.42B
| $133K | ﹤0.01% |
6,502
-3,689
| -36% | -$59.1K |
2026 Q1
1 quarter
|
|
830
Coca-Cola
KO
$399B
| $132K | ﹤0.01% |
+1,619
| New | +$128K |
2026 Q2
0 quarters
|
|
831
Compass Minerals
CMP
$924M
| $131K | ﹤0.01% |
4,222
-814
| -16% | -$23K |
2026 Q1
1 quarter
|
|
832
Freeport-McMoran
FCX
$99B
| $131K | ﹤0.01% |
+2,077
| New | +$134K |
2026 Q2
0 quarters
|
|
833
IPG Photonics
IPGP
$3.15B
| $129K | ﹤0.01% |
+1,102
| New | +$127K |
2026 Q2
0 quarters
|
|
834
Sprinklr
CXM
$1.49B
| $126K | ﹤0.01% |
+24,494
| New | +$130K |
2026 Q2
0 quarters
|
|
835
Opendoor
OPEN
$1.92B
| $126K | ﹤0.01% |
+27,279
| New | +$131K |
2026 Q2
0 quarters
|
|
836
Penguin Solutions Inc
PENG
$3.02B
| $124K | ﹤0.01% |
1,631
+203
| +14% | +$9.24K |
2025 Q4
2 quarters
|
|
837
Whirlpool
WHR
$1.76B
| $121K | ﹤0.01% |
+3,080
| New | +$144K |
2026 Q2
0 quarters
|
|
838
Scansource
SCSC
$1.23B
| $119K | ﹤0.01% |
+2,291
| New | +$100K |
2026 Q2
0 quarters
|
|
839
FuelCell Energy
FCEL
$1.06B
| $119K | ﹤0.01% |
+3,296
| New | +$53.5K |
2026 Q2
0 quarters
|
|
840
Hayward Holdings
HAYW
$2.58B
| $117K | ﹤0.01% |
6,753
-8,260
| -55% | -$121K |
2026 Q1
1 quarter
|
|
841
Maplebear
CART
$12.1B
| $116K | ﹤0.01% |
+2,454
| New | +$103K |
2026 Q2
0 quarters
|
|
842
Pattern Group Inc
PTRN
$3.16B
| $110K | ﹤0.01% |
+4,351
| New | +$73.8K |
2026 Q2
0 quarters
|
|
843
Extra Space Storage
EXR
$29.5B
| $101K | ﹤0.01% |
694
-312,049
| -100% | -$44.6M |
2026 Q1
1 quarter
|
|
844
American Superconductor
AMSC
$1.3B
| $92.5K | ﹤0.01% |
+2,228
| New | +$101K |
2026 Q2
0 quarters
|
|
845
Coeur Mining
CDE
$15.5B
| $90.8K | ﹤0.01% |
+5,564
| New | +$101K |
2026 Q2
0 quarters
|
|
846
Align Technology
ALGN
$10.8B
| $90.4K | ﹤0.01% |
536
-152,170
| -100% | -$26.4M |
2026 Q1
1 quarter
|
|
847
Medical Properties Trust
MPT
$1.61B
| $89.5K | ﹤0.01% |
19,374
+12,855
| +197% | +$63.7K |
2026 Q1
1 quarter
|
|
848
Lincoln Educational Services
LINC
$680M
| $88.1K | ﹤0.01% |
+1,765
| New | +$79.9K |
2026 Q2
0 quarters
|
|
849
LivaNova
LIVN
$4.36B
| $86.6K | ﹤0.01% |
+1,053
| New | +$74.5K |
2026 Q2
0 quarters
|
|
850
Corcept Therapeutics
CORT
$12.7B
| $86.5K | ﹤0.01% |
995
+993
| +49,650% | +$60K |
2026 Q1
1 quarter
|
|
Similar funds
Freestone Grove Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Freestone Grove Partners held 1,397 positions worth $15.6B, up 10% from $14.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Freestone Grove Partners's Q2 2026 filing shows 435 new, 253 increased, 266 reduced and 407 closed positions. Its largest new stake was Abbott: 1,372,846 shares worth $125M. The largest sale was Datadog, an estimated $128M.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 12% a quarter earlier, followed by Financials and Miscellaneous.
- Freestone Grove Partners's largest Q2 2026 buy was Abbott: 1,372,846 shares worth $125M.
- Freestone Grove Partners added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $311M increase.
- Freestone Grove Partners's biggest Q2 2026 reduction was Elastic, cutting an estimated $110M.
- Freestone Grove Partners fully exited Datadog in Q2 2026, selling an estimated $128M.
- Freestone Grove Partners's ten largest holdings make up 22% of its $15.6B portfolio in Q2 2026.
- Freestone Grove Partners opened 435 new positions and closed 407 in Q2 2026.
- Freestone Grove Partners's portfolio value rose 10% quarter-over-quarter to $15.6B.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.